Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD
Waizel M, Todorova M, Masyk M, Wolf K, Rickmann A, Helaiwa K, Blanke B, Szurman P. Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD. BMC Ophthalmol 2017; 17:79.
May 23, 2017
Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD
May 23, 2017
BMC Ophthalmol 2017; 17:79
Waizel Maria, Todorova Margarita, Masyk Michael, Wolf Katharina, Rickmann Annekatrin, Helaiwa Khaled, Blanke Björn R., Szurman Peter
more
